We are live on ! Find out more
TLIS

Talis Biomedical Corporation Common Stock
TLIS

Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

45 hedge funds and large institutions have $269M invested in Talis Biomedical Corporation Common Stock in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$126M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$99.8M
3
BC
Boxer Capital
California
+$25.8M
4
NIP
Nicholas Investment Partners
California
+$18.3M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$17.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Mercer Global Advisors
26
Mercer Global Advisors
Colorado
$257K +$333K +1,336 New
Morgan Stanley
27
Morgan Stanley
New York
$222K +$287K +1,152 New
M&T Bank
28
M&T Bank
New York
$195K +$253K +1,013 New
LCM
29
Laurion Capital Management
New York
$129K +$166K +667 New
Norges Bank
30
Norges Bank
Norway
$129K +$166K +667 New
Tudor Investment Corp
31
Tudor Investment Corp
Connecticut
$129K +$166K +667 New
Janney Montgomery Scott
32
Janney Montgomery Scott
Pennsylvania
$128K +$166K +667 New
TRCT
33
Tower Research Capital (TRC)
New York
$122K +$158K +632 New
Deutsche Bank
34
Deutsche Bank
Germany
$107K +$139K +556 New
EMG
35
ETF Managers Group
New Jersey
$90K +$131K +525 New
Wells Fargo
36
Wells Fargo
California
$53K +$68.8K +276 New
SO
37
STRS Ohio
Ohio
$41K +$53.1K +213 New
UBS Group
38
UBS Group
Switzerland
$41K +$53.4K +214 New
Legal & General Group
39
Legal & General Group
United Kingdom
$17K +$22.2K +89 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$16K +$21.2K +85 New
Osaic Holdings
41
Osaic Holdings
Arizona
$15K +$19.2K +77 New
AIP
42
Ameritas Investment Partners
Nebraska
$14K +$18K +72 New
Citigroup
43
Citigroup
New York
$11K +$14.5K +58 New
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$6K +$7.23K +29 New
AIG
45
American International Group
New York
$99 +$128K +514 New
1
2

TLIS Hedge Fund Activity: Q1 2021 in Review

45 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Talis Biomedical Corporation Common Stock (TLIS) for Q1 2021, worth a combined $269M.

Buyers outnumbered sellers: 45 funds opened new TLIS positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $126M.

  • 45 institutional investors held Talis Biomedical Corporation Common Stock (TLIS) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $269M of Talis Biomedical Corporation Common Stock stock for Q1 2021.
  • 45 funds opened new Talis Biomedical Corporation Common Stock positions in Q1 2021 and 0 closed out, a net change of +45 holders.
  • The largest Talis Biomedical Corporation Common Stock buyer in Q1 2021 was Baker Bros. Advisors, an estimated $126M added.

Based on aggregated 13F filings for Q1 2021.